SynGenis
PrivateLast Round
Growth Equity
Jul 12, 2026
Total Funding Raised
$2.78M
Company Overview
SynGenis is a biotechnology company that specializes in the production and supply of high-quality oligonucleotides for diagnostic and therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SynGenis Comparables
Compare SynGenis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synoligo Biotechnologies | 83% | |
| Messenger Bio | 74% | |
| Danaher Corporation | 72% | |
SynGenis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Jul 12, 2026 | ||||
| Seed | Mar 1, 2021 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 25, 2026
Grew 63% QoQ, from 8 to 13 employees.
- Apr 11, 2026
Grew 71% QoQ, from 7 to 12 employees.
SynGenis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SynGenis's valuation, stock price, and market status.